Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too.

Perehudoff, Katrina; 't Hoen, Ellen; Boulet, Pascale

Perehudoff, Katrina; 't Hoen, Ellen; Boulet, Pascale.

Perehudoff K; Law Centre for Health and Life, Faculty of Law, University of Amsterdam, Amsterdam, The Netherlands katrina.perehudoff@gmail.com.
't Hoen E; WHO Collaborating Centre for Governance, Accountability, and Transparency in the Pharmaceutical Sector, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Boulet P; Medicines Law & Policy, Amsterdam, The Netherlands.

BMJ Glob Health ; 6(4)2021 04.

Article in English | MEDLINE | ID: covidwho-1794507

Subject(s)

Biomedical Technology; COVID-19; Patents as Topic; Technology, Pharmaceutical; COVID-19/prevention & control; Developed Countries; Humans

Keywords

COVID-19; health policy; vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patents as Topic / Technology, Pharmaceutical / Biomedical Technology / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-005518

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google